| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2011 | Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells | Yu S.; Zhang C.; Lin C.-C.; Niu Y.; Lai K.-P.; HONG-CHIANG CHANG ; Yeh S.-D.; Chang C.; Yeh S. | Prostate | 45 | 43 | |
| 2012 | Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts | Yu S.; Yeh C.-R.; Niu Y.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Moses H.L.; Shyr C.-R.; Chang C.; Yeh S. | Prostate | 55 | 50 | |
| 2005 | Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth | Hsu C.-L.; Chen Y.-L.; Ting H.-J.; Lin W.-J.; Yang Z.; Zhang Y.; Wang L.; Wu C.-T.; HONG-CHIANG CHANG ; Yeh S.; Pimplikar S.W.; Chang C. | Molecular Endocrinology | 55 | 54 | |
| 2004 | Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types | Altuwaijri S.; Dong K.L.; Chuang K.-H.; Ting H.-J.; Yang Z.; Xu Q.; Tsai M.-Y.; Yeh S.; Hanchett L.A.; HONG-CHIANG CHANG ; Chang C. | Endocrine | 38 | 38 | |
| 2020 | Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion | Chen J.; Sun Y.; Ou Z.; Yeh S.; Huang C.-P.; You B.; YU-CHIEH TSAI ; Sheu T.-J.; Zu X.; Chang C. | EMBO Reports | 46 | 41 | |
| 2015 | Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals | Dang Q.; Li L.; Xie H.; He D.; Chen J.; Song W.; Chang L.S.; HONG-CHIANG CHANG ; Yeh S.; Chang C. | Molecular Oncology | 36 | 32 | |
| 2009 | CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells | Chen M.; Ni J.; HONG-CHIANG CHANG ; Lin C.-Y.; Muyan M.; Yeh S. | Carcinogenesis | 53 | 50 | |
| 1999 | Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate | Fujimoto N.; Yeh S.; Kang H.-Y.; Inui S.; HONG-CHIANG CHANG ; Mizokami A.; Chang C. | Journal of Biological Chemistry | 253 | 226 | |
| 2020 | Correction to: Androgen receptor regulates expression of skeletal muscle–specific proteins and muscle cell types (Endocrine, (2004), 25, 1, (49-54), 10.1385/ENDO:25:1:49) | Altuwaijri S.; Lee D.K.; Chuang K.-H.; Ting H.-J.; Yang Z.; Xu Q.; Tsai M.-Y.; Yeh S.; Hanchett L.R.A.; HONG-CHIANG CHANG ; Chang C. | Endocrine | 0 | 0 | |
| 2016 | Correction: Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals [Oncotarget. 6, 14, (2015) (12326-12339)] doi: 10.18632/oncotarget.3619. | Xie H.; Li L.; Zhu G.; Dang Q.; Ma Z.; He D.; Chang L.; Song W.; HONG-CHIANG CHANG ; Krolewski J.J.; Nastiuk K.L.; Yeh S.; Chang C. | Oncotarget | 5 | 5 | |
| 2016 | Corrigendum to “Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling” (Molecular Oncology (2015) 9(1) (44–57) (S1574789114001689) (10.1016/j.molonc.2014.07.013)) | Hu S.; Li L.; Yeh S.; Cui Y.; Li X.; HONG-CHIANG CHANG ; Jin J.; Chang C. | Molecular Oncology | 1 | 1 | |
| 2020 | Corrigendum to: susceptibility to Autoimmunity and B Cell Resistance to Apoptosis in Mice Lacking Androgen Receptor in B Cells (Molecular Endocrinology (2009) 23:4: (444–453) DOi: 10.1210/me.2008-0106) | Altuwaijri S.; Chuang K.-H.; Lai K.-P.; Lai J.-J.; Lin H.-Y.; Young F.M.; Bottaro A.; Tsai M.-Y.; Zeng W.-P.; HONG-CHIANG CHANG ; Yeh S.; Chang C. | Endocrinology (United States) | 0 | 0 | |
| 1999 | Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells | Yeh S.; Kang H.-Y.; Miyamoto H.; Nishimura K.; HONG-CHIANG CHANG ; Ting H.-J.; Rahman M.; Lin H.-K.; Fujimoto N.; Hu Y.-C.; Mizokami A.; Huang K.-E.; Chang C. | Endocrine | 68 | 66 | |
| 1999 | Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators | Yeh S.; HONG-CHIANG CHANG ; Miyamoto H.; Takatera H.; Rahman M.; Kang H.-Y.; Thin T.H.; Lin H.-K.; Chang C. | Keio Journal of Medicine | 50 | 0 | |
| 2009 | The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer | Yu S.-Q.; Lai K.-P.; Xia S.-J.; HONG-CHIANG CHANG ; Chang C.; Yeh S. | Asian Journal of Andrology | 23 | 24 | |
| 2002 | A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth | Miyamoto H.; Rahman M.; Takatera H.; Kang H.-Y.; Yeh S.; HONG-CHIANG CHANG ; Nishimura K.; Fujimoto N.; Chang C. | Journal of Biological Chemistry | 55 | 53 | |
| 2014 | Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo | Hsu I.; Yeh C.-R.; Slavin S.; Miyamoto H.; Netto G.J.; YU-CHIEH TSAI ; Muyan M.; Wu X.-R.; Messing E.M.; Guancial E.A.; Yeh S. | Oncotarget | 54 | 49 | |
| 2000 | Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer | Yeh S.; Sampson E.R.; Dong Kun Lee, Kim E.; Hsu C.-L.; Chen Y.-L.; HONG-CHIANG CHANG ; Altuwaijri S.; Huang K.-E.; Chang C. | Journal of the Formosan Medical Association | 18 | 16 | |
| 2013 | Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine | Barregard L.; M?ller P.; Henriksen T.; Mistry V.; Koppen G.; Rossner P.; Sram R.J.; Weimann A.; Poulsen H.E.; Nataf R.; Andreoli R.; Manini P.; Marczylo T.; Lam P.; Evans M.D.; Kasai H.; Kawai K.; Li Y.-S.; Sakai K.; Singh R.; Teichert F.; Farmer P.B.; Rozalski R.; Gackowski D.; Siomek A.; Saez G.T.; Cerda C.; Broberg K.; Lindh C.; Hossain M.B.; Haghdoost S.; Hu C.-W.; Chao M.-R.; KUEN-YUH WU ; Orhan H.; Senduran N.; Smith R.J.; Santella R.M.; Su Y.; Cortez C.; Yeh S.; Olinski R.; Loft S.; Cooke M.S. | Antioxidants and Redox Signaling | 114 | 114 | |
| 2015 | Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/ TGF-β1/Smad/MMP9 signals | Xie H.; Li L.; Zhu G.; Dang Q.; Ma Z.; He D.; Chang L.; Song W.; HONG-CHIANG CHANG ; Krolewski J.J.; Nastiuk K.L.; Yeh S.; Chang C. | Oncotarget | 41 | 39 | |
